Ponziceuticals within the medical industrial complex
- PMID: 19581625
- PMCID: PMC2704400
- DOI: 10.1503/cmaj.091015
Ponziceuticals within the medical industrial complex
Figures
Similar articles
-
[Financial capital versus medical-industrial complex: challenges for the regulatory agencies].Cien Saude Colet. 2008 Sep-Oct;13(5):1619-26. doi: 10.1590/s1413-81232008000500025. Cien Saude Colet. 2008. PMID: 18813662 Spanish.
-
By the numbers. Largest healthcare financing companies ranked by amount of syndicated loans in the healthcare sector underwritten from Sept. 1, 2006, through April 9, 2007.Mod Healthc. 2007 May 21;37(21):46. Mod Healthc. 2007. PMID: 17824191 No abstract available.
-
Wall Street's love affair with health care.Health Aff (Millwood). 1998 Jul-Aug;17(4):126-31. doi: 10.1377/hlthaff.17.4.126. Health Aff (Millwood). 1998. PMID: 9691555 No abstract available.
-
Capital finance and ownership conversions in health care.Health Aff (Millwood). 2000 Jan-Feb;19(1):56-71. doi: 10.1377/hlthaff.19.1.56. Health Aff (Millwood). 2000. PMID: 10645073 Review.
-
Overview of investment and financing trends in the hospital industry.J Healthc Manag. 2005 Jan-Feb;50(1):12-5. J Healthc Manag. 2005. PMID: 15729903 Review. No abstract available.
References
-
- Ridker PM, Danielson E, Fonseca F, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New Eng J Med. 2009;359:2195–207. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources